What is the mechanism of action of atropine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Mechanism of Action of Atropine

Atropine is an antimuscarinic agent that competitively antagonizes acetylcholine at muscarinic receptors on structures innervated by postganglionic cholinergic nerves, including exocrine glands, smooth muscle, and cardiac muscle. 1

Core Pharmacologic Mechanism

Atropine functions through competitive or surmountable antagonism at muscarinic receptors, meaning its blockade can be overcome by increasing acetylcholine concentrations at receptor sites (such as with anticholinesterase agents) 1. The drug specifically targets peripheral structures that are stimulated or inhibited by muscarine.

Key Receptor Interactions

  • Primary target: Muscarinic receptors on postganglionic cholinergic nerve-innervated structures
  • Mechanism type: Competitive antagonism that blocks acetylcholine binding
  • Does NOT affect: Nicotinic receptors at neuromuscular junctions or ganglia—therefore atropine does not reverse paralysis from cholinergic excess 2, 3

Clinical Effects by System

Cardiovascular Effects

Atropine blocks parasympathetic (vagal) control of the heart, producing:

  • Tachycardia through paralysis of vagal control (though small doses may initially cause transient bradycardia before characteristic tachycardia develops) 1
  • Abolishes reflex vagal cardiac slowing or asystole
  • Prevents bradycardia from anticholinesterase agents or parasympathomimetic drugs 1

Respiratory Effects

  • Bronchodilation through blockade of muscarinic receptors in bronchial smooth muscle
  • Reduces bronchorrhea (excessive bronchial secretions)
  • More potent and prolonged effect on bronchial muscle compared to scopolamine 1

Secretory Effects

Blocks muscarinic receptors on exocrine glands, reducing:

  • Salivation
  • Lacrimation
  • Sweating (can cause "atropine fever" in infants/small children) 1
  • Bronchial secretions

Gastrointestinal Effects

  • Inhibits intestinal smooth muscle through muscarinic blockade
  • More potent effect on intestinal muscle than scopolamine 1

Special Context: Organophosphate/Carbamate Poisoning

In cholinesterase inhibitor poisoning, atropine blocks parasympathetic overstimulation, mitigating bronchorrhea, bradycardia, bronchospasm, and CNS effects 2, 3. However, it does NOT block acetylcholine excess at neuromuscular junctions or nicotinic ganglia, so it does not reverse paralysis—oximes are required for nicotinic effects 2, 3.

Important Caveats

  • Dose-dependent effects: Atropine exhibits biphasic actions, with very low doses potentially causing initial stimulation before characteristic blockade occurs 1
  • Delayed onset: After IV administration, peak effects on heart rate and secretions are delayed 7-8 minutes despite rapid drug delivery 1
  • CNS effects: Unlike scopolamine, atropine in clinical doses does not depress the CNS but may stimulate medullary and higher cerebral centers 1
  • Weaker effects: Atropine's action on iris, ciliary body, and certain secretory glands is weaker than scopolamine 1

References

Related Questions

What are the bedside decision‑making considerations for enteral and parenteral nutrition, including feeding during vasopressor therapy, choice of gastric versus post‑pyloric feeding, and indications for supplemental parenteral nutrition?
What are the indications, dosing guidelines, administration method, and contraindications for using glutamine granules in patients?
For a patient with intracranial hemorrhage, should a standard 3‑in‑1 parenteral nutrition (amino acids, lipids, and dextrose) be used?
What effect does atropine have on L-type calcium channels?
What is the appropriate management of suspected atropine toxicity?
Apart from valproate and lamotrigine, which antiepileptic drug is appropriate to reduce aggression in a patient with primary generalized seizure disorder?
Why is atropine ineffective in high-degree atrioventricular (AV) block (e.g., Mobitz II second-degree block or third-degree block)?
Is there a less invasive abdominal procedure that removes excess skin and subcutaneous fat without requiring rectus abdominis muscle plication?
Can a man have elevated serum testosterone without medication, and could this be contributing to his refractory hypertension?
Is acetaminophen (Tylenol) with codeine 3 (300 mg acetaminophen + 30 mg codeine) safe during pregnancy?
What is the appropriate vitamin D3 supplementation dose for a patient with a serum 25‑hydroxy vitamin D level of 39 ng/mL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.